Magnetic resonance imaging (MRI) has the great potential in the early detection
preoperative planning and progress prediction of breast cancer. As one of the research hotspots
radiomics can evaluate the heterogeneity of whole tumor
which has the important role in the clinical application. This article reviewed the application of MRI radiomics in the differential diagnosis between malignant and benign tumors
identification of breast cancer subtypes
assessment of response to neoadjuvant chemotherapy
and evaluation of prognostic factors in breast cancer.